Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
Last trade$8.40
Day change-$0.305 (-3.51%)
Day range$8.33 – $8.69
Volume2,101,346
Market cap$1.59B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.59B
Price / earnings
—
Price / book
1.22×
Price / sales
0.64×
EV / sales
0.7×
EV / EBITDA
7.34×
Profitability
Earnings per share
-$0.85
Return on assets
-5.58%
Return on equity
-11.96%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.77×
Current ratio
0.87×
Quick ratio
0.84×
Cash ratio
0.6×
Cash flow
Price / cash flow
5.91×
Price / free cash flow
6.89×
Free cash flow
$230.26M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TDOC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$605.1M
$606.93M
$613.85M
$642.27M
$626.44M
$631.9M
$629.37M
$640.49M
Cost of revenue
$190.26M
$190.84M
$197.53M
$197.05M
$187.18M
$190.54M
$196.83M
$188.93M
Gross profit
$414.84M
$416.09M
$416.32M
$445.22M
$439.26M
$441.36M
$432.54M
$451.56M
Selling, general and administrative
$280.96M
$296.82M
$304.9M
$305.74M
$318.78M
$325.61M
$329.65M
$327.45M
Research and development
$65.55M
$62.86M
$67.87M
$71.61M
$67.57M
$68.78M
$69.96M
$76.75M
Total operating expenses
$442.94M
$451.49M
$478.09M
$481.22M
$491.22M
$493.09M
$553.15M
$499.78M
Operating income
-$28.1M
-$35.4M
-$61.77M
-$36M
-$51.96M
-$51.73M
-$120.61M
-$48.22M
Interest expense
-$4.94M
-$5.11M
-$5.37M
-$4.95M
-$4.53M
-$4.47M
-$5.77M
-$6.85M
Income before taxes
-$26.28M
-$37.91M
-$60.84M
-$33.62M
-$50.22M
-$40.42M
-$111.27M
-$48.17M
Income taxes
$655K
$997K
$3M
-$8.48M
-$715K
-$7.76M
-$18.26M
$238K
Net income
-$26.93M
-$38.91M
-$63.84M
-$25.14M
-$49.51M
-$32.66M
-$93.01M
-$48.41M
Net income attributable to common shareholders
-$26.93M
-$38.91M
-$63.84M
-$25.14M
-$49.51M
-$32.66M
-$93.01M
-$48.41M
EBITDA
$68.34M
$56.41M
$43.56M
$67.87M
$52.91M
$46.97M
$32.93M
$47.36M
Basic earnings per share
-$0.15
-$0.21
-$0.36
-$0.14
-$0.28
-$0.19
-$0.53
-$0.28
Diluted earnings per share
-$0.15
-$0.21
-$0.36
-$0.14
-$0.28
-$0.19
-$0.53
-$0.28
Recent news
Company coverage with links to the original publishers.
The global telehealth market is experiencing significant growth, projected to expand from $77.4 billion in 2025 to $187.5 billion by 2033. Key developments include AI-powered diagnostics, remote patient monitoring, and virtual care expansion. Rocket Doctor AI joined the Altais network to expand telehealth services in California, while competitors like Teladoc Health, Amwell, Hims & Hers, and Doximity launched new AI capabilities and research initiatives to enhance digital healthcare delivery.
Cathie Wood's Ark Invest has been buying Archer Aviation stock during its 62% decline, but the article examines Ark's track record of buying beaten-down stocks. Ark Innovation ETF has underperformed the S&P 500 by 110% over five years, with notable losses in past holdings like Teladoc (down 95%), Zoom (down 65%), and Ginkgo Bioworks (down 98%). The article cautions that investors should evaluate Archer based on its own business fundamentals and catalysts rather than Ark's historical performance.
Teladoc reported Q3 2026 earnings with strategic shifts toward in-network insurance coverage for BetterHelp, launched the unified Teladoc 1 care platform for 2027, and outlined a two-phase refinancing plan to manage $1 billion in convertible notes due June 2027. The company achieved $605 million in consolidated revenue and $32 million in BetterHelp insurance revenue, with integrated care membership reaching 100.1 million.
Teladoc reported Q3 2026 revenue of $605.1 million, down 3.4% year-over-year but beating consensus estimates by 3.34%. The company posted an EPS of -$0.15, significantly outperforming the -$0.23 estimate. Key metrics showed mixed results: Integrated Care revenue grew 2.3% while BetterHelp revenue declined 12.8%. The stock has gained 12.2% over the past month and carries a Zacks Rank #3 (Hold) rating.
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, expanding at a 20.2% CAGR. Growth is driven by rising chronic disease management demand, expanding reimbursement coverage, and maturing wearable sensor technology, enabling a shift from episodic facility-centered care to continuous connected care models.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.